Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

A stem cell treatment commonly used for blood cancer appears effective in treating one form of MS The treatment has been available since the 1990s but questions about safety and difficulty have ...

(BOSTON) — Multiple sclerosis (MS) is a devastating autoimmune disease that destroys the protective myelin covering around nerves, disrupting communication between the brain and body, and causing ...

Multiple sclerosis (MS) is an autoimmune disease that destroys the protective myelin covering around nerves. Every five minutes, someone is diagnosed with the disease around the world, adding to about ...

Monoclonal antibody DMTs, especially anti-CD20 therapies, effectively prevent relapses but have limited impact on progressive MS. Progressive MS involves compartmentalized CNS inflammation, with ...

In the brain section of an MS patient, the neurons are shown in green and the target antigen MLC1 in red. Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused ...

Multiple sclerosis (MS) is a devastating autoimmune disease that destroys the protective myelin covering around nerves, disrupting communication between the brain and body, and causing patients' ...

Scientists have demonstrated in mouse studies that specially designed probiotics can reduce brain inflammation associated with diseases like multiple sclerosis. The study points to new potential ...